-
FDA approves new drug for treatment-resistant forms of tuberculosis that affects the lungs
worldpharmanews
August 16, 2019
The U.S. Food and Drug Administration today approved Pretomanid Tablets in combination with bedaquiline and linezolid for the treatment of a specific type of highly treatment-resistant tuberculosis (TB) of the lungs.
-
FDA Approves Drug for Treatment-Resistant forms of TB
americanpharmaceuticalreview
August 15, 2019
The U.S. Food and Drug Administration (FDA) approved Pretomanid Tablets in combination with bedaquiline and linezolid for the treatment of a specific type of highly treatment-resistant tuberculosis (TB) of the lungs.
-
Thermally-stable TB vaccine developed using new technique
europeanpharmaceuticalreview
August 09, 2019
A new process developed by the University of Bath protects a TB antigen and a novel vaccine adjuvant from heat damage.
-
J&J launches research consortium for new drugs against TB
pharmaceutical-technology
July 25, 2019
Johnson & Johnson (J&J) has formed an international research consortium to focus on the discovery and development of new antibiotics to treat tuberculosis (TB).
-
Vaccine trial launched by ICMR to prevent TB spread
expresspharma
July 18, 2019
The Indian Council of Medical Research launched a vaccine trial to prevent occurrence of TB among close contacts of a TB case (patient). This vaccine trial is an important step in prevention and decreasing the burden of this disease.
-
Evotec Receives $23.8M TB Grant
contractpharma
June 12, 2019
Aims to generate standardized, high-quality preclinical data to support novel regimen selection and development.
-
Recs Updated for TB Screening, Treatment in Health Care Workers
drugs
May 17, 2019
Recs Updated for TB Screening, Treatment in Health Care Workers.
-
Collaboration to produce new clinical stage TB drug candidates
europeanpharmaceuticalreview
May 15, 2019
The National Institute of Allergy and Infectious Diseases (NIAID) has awarded TB Alliance a CETR grant for tuberculosis drug development.
-
Repurposing cancer drugs may lead to a new approach to treating TB
europeanpharmaceuticalreview
April 22, 2019
Promising experimental cancer chemotherapy drugs may help knock out another life-threatening disease: tuberculosis (TB)…
-
NIAID plan for in-depth tuberculosis research
europeanpharmaceuticalreview
April 18, 2019
NIAID has released a plan for research in the infectious disease TB in order to strengthen efforts and resolve to attack this disease…